Results 181 to 190 of about 4,106,658 (410)

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction [PDF]

open access: green, 1974
P C Elwood   +7 more
openalex   +1 more source

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

open access: yesMolecular Oncology, EarlyView.
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin   +14 more
wiley   +1 more source

Effect of high-definition transcranial direct current stimulation among late-subacute and chronic stroke survivors with fatigue: A randomized-controlled crossover trial protocol

open access: yesMethodsX
Post-stroke fatigue (PSF) is a commonly overlooked symptom that impacts daily functioning and quality of life. It is caused by altered functional connectivity within the brain networks, which can potentially be influenced by neuromodulation.
Akhila Jagadish   +5 more
doaj  

Dynamic borrowing from historical controls via the synthetic prior with covariates in randomized clinical trials [PDF]

open access: yesarXiv
Motivated by a rheumatoid arthritis clinical trial, we propose a new Bayesian method called SPx, standing for synthetic prior with covariates, to borrow information from historical trials to reduce the control group size in a new trial. The method involves a novel use of Bayesian model averaging to balance between multiple possible relationships ...
arxiv  

OVERVIEW OF RANDOMIZED CONTROLLED TRIALS [PDF]

open access: yes, 2013
Randomized controlled trials are considered to be the gold standard in clinical studies to establish level of evidence in medical research. But, they are not easy to conduct and various other aspects have to be looked into.
M.DEODURG, PRIYADARSHINI   +2 more
core   +1 more source

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial

open access: yesMolecular Oncology, EarlyView.
Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate
Luka Tandaric   +11 more
wiley   +1 more source

Efficacy of acupuncture as an adjunctive treatment to patients with stable COPD: a multicenter, randomized, sham-controlled trial protocol

open access: yesBMC Complementary Medicine and Therapies
Background Chronic obstructive pulmonary disease (COPD) is a common respiratory disease and the third leading cause of death worldwide. Previous evidence has shown that acupuncture may be an effective complementary alternative therapy for stable COPD ...
Liuyang Huang   +31 more
doaj   +1 more source

Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial

open access: yesTrials, 2018
Background Poststroke depression is closely related to increased mortality in stroke patients. Compared with antidepressants, electroacupuncture (EA) treatment for poststroke depression (PSD) has relatively more stable effectiveness and can reduce side ...
Wa Cai   +3 more
doaj   +1 more source

Telerehabilitation for aphasia – protocol of a pragmatic, exploratory, pilot randomized controlled trial [PDF]

open access: yes, 2018
Background The Cochrane review on the effectiveness of speech and language therapy for aphasia following stroke suggests intensity of therapy is a key predictor for outcome.
Becker, Frank   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy